Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-16T08:42:42.748Z Has data issue: false hasContentIssue false

Combination treatment of depression

Published online by Cambridge University Press:  02 January 2018

Ian Anderson*
Affiliation:
School of Psychiatry and Behavioural Sciences, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © The Royal College of Psychiatrists 

References

Beasley, C. M., Sayler, M. E., Cunningham, G. E., et al (1990) Fluoxetine in tricyclic refractory major depressive disorder. Journal of Affective Disorders, 20, 193200.CrossRefGoogle ScholarPubMed
Delgado, P. L., Price, L. H., Charney, D. S., et al (1988) Efficacy of fluvoxamine in treatment-refractory depression. Journal of Affective Disorders. 15, 5560.CrossRefGoogle ScholarPubMed
Lingjaerde, O., Bratfos, O., Bratlid, T., et al (1983) A doubleblind comparison of zimelidine and desipramine in endogenous depression. Acta Psychiatrica Scandinavica, 68, 2230.CrossRefGoogle ScholarPubMed
Nolen, W. A., van de Putte, J. J., Digken, W. A., et al (1988) Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial cross-over study on the effects of oxaprotiline and fluvoxamine. Acta Psychiatrica Scandinavica, 78, 668675.CrossRefGoogle Scholar
White, K., Wykoff, W., Tynes, L. L., et al (1990) Fluvoxamine in the treatment of tricyclic-resistant depression. Psychiatry Journal of the University of Ottawa, 15, 156158.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.